oxidopamine has been researched along with Fibrosarcoma in 1 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Fibrosarcoma: A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lackovicova, L | 1 |
Banovska, L | 1 |
Bundzikova, J | 1 |
Janega, P | 1 |
Bizik, J | 1 |
Kiss, A | 1 |
Mravec, B | 1 |
1 other study available for oxidopamine and Fibrosarcoma
Article | Year |
---|---|
Chemical sympathectomy suppresses fibrosarcoma development and improves survival of tumor-bearing rats.
Topics: Animals; Body Weight; Fibrosarcoma; Humans; Immunoenzyme Techniques; Injections, Intraperitoneal; Ma | 2011 |